UiPath
PATH
$13.75
-0.87%
UiPath, Inc. is a software company that provides an end-to-end enterprise automation platform, initially centered on robotic process automation (RPA) and now expanding into broader AI-driven automation solutions. As a pioneer and leader in the RPA market, UiPath differentiates itself through its computer vision technology and a comprehensive platform that automates repetitive tasks across various industries. The current investor narrative revolves around UiPath's transition to profitability and its strategic positioning in the emerging 'agentic AI' space, with recent strong quarterly results and raised outlook fueling optimism, while concerns about competition from generative AI and a recent sharp stock drop on September 4, 2026, add to the debate.…
PATH
UiPath
$13.75
Related headlines
Investment Opinion: Should I buy PATH Today?
Based on the analysis, I rate UiPath as a Hold. The company has shown strong revenue acceleration and achieved profitability, but the stock is trading slightly above the average analyst target of $14.31, and the consensus rating is 'Hold' with a mean of 2.8. The thesis is that UiPath is a well-positioned automation player with improving fundamentals, but the near-term upside is limited given the cautious analyst sentiment and competitive risks.
Sign up to view all
PATH 12-Month Price Forecast
The AI assessment is neutral with medium confidence. UiPath's revenue growth is solid and accelerating, but the stock's valuation is not compelling relative to analyst targets, and the competitive threat from generative AI is a significant overhang. The recent sharp drop indicates that the market is reassessing the company's prospects, and the next few quarters will be crucial in determining whether UiPath can sustain its growth and profitability. If the company delivers strong results and raises guidance, the stance would upgrade to bullish; conversely, a miss or negative news on the AI front would lead to a bearish stance.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on UiPath's 12-month outlook, with a consensus price target around $16.85 and implied upside of +22.6% versus the current price.
Average Target
$16.85
0 analysts
Implied Upside
+22.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$11 - $23
Analyst target range
UiPath is covered by 16 analysts, with a consensus recommendation of 'Hold' (mean rating of 2.8, where 1 is Strong Buy and 5 is Sell). The average target price is $14.31, which is 5.8% below the current price of $15.19, implying a slight downside. The distribution includes 4 Buy ratings, 8 Hold ratings, and 4 Sell ratings, indicating a cautious sentiment. Recent actions from institutional ratings show a mix of Neutral, Market Perform, and Buy ratings, with no major upgrades or downgrades in the past few months, suggesting analysts are waiting for more clarity on growth sustainability.
Bulls vs Bears: PATH Investment Factors
UiPath presents a mixed picture: strong revenue acceleration, high gross margins, and a solid balance sheet are countered by a sharp recent stock drop, cautious analyst sentiment, and competitive pressures from generative AI. The bull case rests on the company's ability to transition from RPA to AI-driven automation and sustain double-digit growth, while the bear case hinges on the risk that AI-native solutions could render its platform obsolete. Currently, the evidence is balanced but slightly tilted bearish given the recent price action and analyst targets, yet the accelerating growth and profitability improvements provide a credible path for upside. The most critical tension is whether UiPath can successfully navigate the shift to agentic AI without losing market share to more agile competitors.
Bullish
- Revenue growth accelerating to 17.3% YoY: Q1 FY2027 revenue of $418.4 million grew 17.3% YoY, up from 16.4% in Q4 FY2026 and a dramatic improvement from the 1.5% growth in Q2 FY2026. This acceleration signals that UiPath's platform is gaining traction, likely driven by increased demand for automation and AI solutions.
- Strong gross margin of 83%: UiPath maintains a gross margin of 82.98%, reflecting a highly scalable software model with low incremental costs. This high margin provides ample room for operating leverage as revenue grows, supporting future profitability expansion.
- Positive net income and EPS of $0.04: The company achieved net income of $22.5 million in Q1 FY2027, a turnaround from the net loss of $22.6 million in the same quarter last year. This profitability milestone, with diluted EPS of $0.04, demonstrates that UiPath's business model is now generating sustainable earnings.
- Strong balance sheet with low debt: UiPath has a debt-to-equity ratio of just 0.039 and a current ratio of 2.48, indicating a solid liquidity position. This financial stability provides a cushion for investments in AI and expansion without the risk of leverage.
Bearish
- Stock dropped 16.6% on September 4, 2026: The stock plummeted 16.6% in a single day, from $18.22 to $15.19, erasing a significant portion of its recent gains. This sharp decline suggests investor concerns about growth sustainability or competitive threats, and it may indicate that the market is reassessing the company's valuation.
- Analyst consensus is Hold with downside to target: The average analyst target price is $14.31, which is 5.8% below the current price of $15.19. With a consensus rating of 'Hold' (mean 2.8) and 4 Sell ratings out of 16 analysts, the sell-side is cautious, implying limited near-term upside.
- Negative PEG ratio due to earnings volatility: The PEG ratio is -0.05, reflecting negative expected earnings growth in the near term. This is partly due to one-time tax benefits in prior quarters, but it signals that earnings quality is inconsistent, which could deter growth investors.
- High valuation with EV/EBITDA of 50.9x: Despite a forward PE of 16.4x, the EV/EBITDA multiple is a steep 50.9x, indicating that the market is pricing in substantial EBITDA growth. If profitability improvements stall, the stock could face multiple compression.
PATH Technical Analysis
UiPath's stock has demonstrated a robust recovery over the past year, with a 1-year price change of +40.0%, significantly outperforming the S&P 500's +18.65% over the same period. The current price of $15.19 sits at 76.5% of its 52-week range (low $9.20, high $19.84), indicating a strong upward trend from its lows but still below the peak. This positioning suggests the stock is in a sustained uptrend, though it has pulled back from recent highs, which could signal either a healthy consolidation or early signs of momentum exhaustion.
Beta
1.02
1.02x market volatility
Max Drawdown
-51.4%
Largest decline past year
52-Week Range
$9-$20
Price range past year
Annual Return
+17.6%
Cumulative gain past year
| Period | PATH Return | S&P 500 |
|---|---|---|
| 1m | -9.9% | -1.1% |
| 3m | +30.3% | +3.0% |
| 6m | +18.7% | +15.4% |
| 1y | +17.6% | +16.2% |
| ytd | -13.4% | +12.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PATH Fundamental Analysis
UiPath's revenue growth has been robust, with the most recent quarter (Q1 FY2027, ending April 30, 2026) reporting revenue of $418.4 million, a 17.3% year-over-year increase. This growth is accelerating from the previous quarter's 16.4% YoY growth (Q4 FY2026 revenue of $481.1 million) and represents a significant improvement from the 1.5% growth in Q2 FY2026. The growth is driven by strong subscription services revenue of $252.9 million and license revenue of $149.3 million, while professional services contribute a smaller portion. This acceleration suggests that UiPath's platform is gaining traction, likely benefiting from increased demand for automation and AI solutions.
Quarterly Revenue
$418382000.0B
2026-04
Revenue YoY Growth
+17.3%
YoY Comparison
Gross Margin
81.1%
Latest Quarter
Free Cash Flow
$375234000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PATH Overvalued?
Given UiPath's positive net income, the PE ratio is the primary valuation metric. The trailing PE is 24.2x, while the forward PE is 16.4x, indicating that the market expects significant earnings growth. The gap between trailing and forward PE implies an expected earnings increase of approximately 48%, which is aggressive but supported by recent profitability improvements. The PEG ratio is negative (-0.05) due to negative earnings growth expectations in the near term, which is a red flag, but this is likely distorted by one-time tax benefits in previous quarters.
PE
24.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 11x~96x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
50.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are moderate. UiPath's debt-to-equity ratio is a low 0.039, and it holds a current ratio of 2.48, indicating strong liquidity and minimal financial leverage. However, the company's operating margin is thin at 3.8%, and its net income has been volatile, swinging from a net loss of $22.6 million in Q1 FY2026 to a profit of $22.5 million in Q1 FY2027, partly due to tax benefits. The negative PEG ratio (-0.05) and the high EV/EBITDA of 50.9x suggest that the market expects significant earnings growth, and any shortfall could lead to a de-rating. Revenue concentration in subscription and license revenue (96% of total) is a positive, but the reliance on continued growth to justify valuation is a risk if the automation market matures faster than expected.
FAQ
The key risks of holding PATH include: (1) competitive disruption from generative AI, which could render its RPA platform obsolete (a risk highlighted in recent news); (2) financial risks from thin operating margins of 3.8% and volatile earnings, as seen in the negative PEG ratio; (3) market risks from a high EV/EBITDA of 50.9x, which could lead to multiple compression if growth slows; and (4) company-specific risks such as the recent 16.6% stock drop, which may indicate underlying issues. The most severe risk is a scenario where growth decelerates below 10%, leading to a de-rating and a potential drop to the 52-week low of $9.20.
The 12-month forecast for PATH is mixed. In the base case (50% probability), the stock trades in a range of $13 to $16, with an average target of $14.31, implying a slight downside. In the bull case (25% probability), the stock could reach $22, driven by strong AI adoption and revenue growth above 20%. In the bear case (25% probability), the stock could fall to $9.20, if growth stalls due to competitive pressures. The most likely scenario is the base case, where UiPath continues to grow at a mid-teens rate but faces headwinds from competition and valuation concerns.
PATH is fairly valued relative to its growth prospects. The forward PE of 16.4x is reasonable for a software company with 17.3% revenue growth, but the EV/EBITDA of 50.9x is high, indicating that the market expects significant EBITDA growth. Compared to the sector, PATH's PS ratio of 4.2x is in line with peers, but the negative PEG ratio suggests that earnings growth is expected to be volatile. The market is pricing in continued double-digit growth and profitability improvements, but not a massive premium, as the stock trades below its 52-week high of $19.84. Overall, the valuation is not a bargain, but it is not excessive either.
PATH is a hold, not a buy, at the current price of $15.19. The average analyst target is $14.31, implying a 5.8% downside, and the consensus rating is 'Hold' with 4 Sell ratings. The company has strong fundamentals, with revenue growth of 17.3% and positive net income, but the stock is not undervalued. A good entry point would be below $12, where the downside to the 52-week low of $9.20 is more limited, and the risk/reward becomes more favorable. For investors with a high risk tolerance and a long-term view, PATH could be a buy on dips, but for most, waiting for a better price is prudent.
PATH is more suitable for long-term investment, given its growth stage and volatility. The stock has a beta of 0.96, indicating market-like volatility, and the recent 16.6% drop highlights short-term risks. However, the company's strong revenue growth, high gross margins, and low debt provide a foundation for long-term value creation if it successfully navigates the AI transition. For short-term traders, the stock offers opportunities due to its volatility, but the analyst consensus is 'Hold,' suggesting limited near-term upside. A minimum holding period of 3-5 years is recommended to allow the company to capitalize on the agentic AI trend and achieve sustained profitability.